| Literature DB >> 11074266 |
D R Howlett1, D L Simmons, C Dingwall, G Christie.
Abstract
The deposition of beta-amyloid (Abeta) in the brain is a neuropathological feature of Alzheimer's disease. Abeta is cleaved from its precursor protein (APP) by processing at its N and C termini by enzymes known as beta- and gamma-secretases,respectively. The identity of these enzymes has been elusive but the search for the N-terminal secretase might have ended recently with the almost simultaneous publication by five major laboratories claiming a transmembrane aspartic proteinase to be the long sought after beta-secretase. Even at this early stage of its characterization, this aspartic proteinase fulfils many of the key criteria necessary for beta-secretase. The race is now on to develop inhibitors that could prove effective in halting the progression of Alzheimer's disease.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11074266 DOI: 10.1016/s0166-2236(00)01647-7
Source DB: PubMed Journal: Trends Neurosci ISSN: 0166-2236 Impact factor: 13.837